Browsing: Conditions

The Social Security Administration said on Tuesday that it is adding 14 conditions to its fast-track disability list, which can help people with these conditions speed up the process of receiving benefits. 

Foundation models (FMs) are driving a prominent shift in biomedical imaging, from task-specific models to unified backbone models for diverse tasks. This opens an avenue to integrate imaging, pathology, clinical records and genomics data into a composite system. However, this vision contrasts sharply with modern medicine’s trajectory towards more granular sub-specialization. This tension, coupled with…

Renewal of FDA’s Priority Review Voucher program is driving a rebound in U.S. rare disease biotech investment, while the UK continues to lag

Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) reported Q2 CY2026 results exceeding the market’s revenue expectations , with sales up 25.9% year on year to $266 million. On the other hand, the company’s full-year revenue guidance of $1.11 billion at the midpoint came in 1% below analysts’ estimates. Its non-GAAP profit of $2.21 per share was…

CNBC Cures is proudly under AstraZeneca Rare Disease, whose support enables our journalism to elevate stories that advance research, innovation and patient care in rare diseases

Miss. (WLBT) – Pediatricians at TrustCare Kids in Brandon say they have already diagnosed children with COVID, the flu, and strep throat in the first weeks of the new school year

ByAmanda Greenwood Newsweek is a Trust Project member See more of our trusted coverage when you search.to see more of our trusted coverage when you search.

CHRONIC kidney disease (CKD) risk increased after unilateral nephrectomy in patients with advanced age, diabetes mellitus, lower preoperative kidney function, and radical nephrectomy, according to a systematic review and meta-analysis of 26 cohort studies involving 13,321 patients. The findings highlighted several preoperative and surgical factors associated with incident CKD and may help inform risk assessment before surgery. 

Medical innovation has transformed our lives, but hardly anyone realizes it. You can tell people that global life expectancy has doubled in a century and watch it fail to register – it just sounds like an abstract number, and numbers don’t convey how different life used to be. So let me describe it another way

BioCryst Pharmaceuticals (NASDAQ:BCRX) closed at $9.84 on August 10, 2026, giving the Durham-based rare-disease specialist a market cap of roughly $2.5 billion. Shares are up 26.2% year to date and 18.6% over one year, though still down 35.3% over five years. What changed is the P&L